Carsten Stephan

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers

Catharine M. Sturgeon, Michael J. Duffy, Ulf‐Håkan Stenman et al. · Clinical Chemistry · 2008 · 1.1K citations

Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma

Annika Schaefer, Monika Jung, Hans‐Joachim Mollenkopf et al. · International Journal of Cancer · 2009 · 613 citations · Full text

Microrna Profiling, Prognostic Biomarkers, Urology +13

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy

Wilko Weichert, A.-E. Roske, Volker Gekeler et al. · British Journal of Cancer · 2008 · 474 citations · Full text

Histone Modifications, Chromatin, Hdac Inhibitors +15

Robust MicroRNA Stability in Degraded RNA Preparations from Human Tissue and Cell Samples

Monika Jung, Annika Schaefer, Isabel Steiner et al. · Clinical Chemistry · 2010 · 295 citations · Full text

Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours

Florian Jentzmik, Carsten Stephan, Kurt Miller et al. · European Urology · 2010 · 231 citations

Urology, Surgical Oncology, Aggressive Tumours +6